Personalisation: The key to long-term success in organ transplantation
Personalised medicine has become essential in practically every field of healthcare, but tailored medicine is extremely vital when it comes to organ transplantation.
Making the UK a lung research superpower will save lives
Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, explains why prioritising lung research is the best way to improve the nation’s health.
Overcoming global inequities in cognitive healthcare to combat dementia
CEO of ViewMind Inc, Mark Edwards, discusses overcoming global inequities in cognitive healthcare to combat the dementia epidemic.
Western diets high in fat and sugar cause non-alcoholic fatty liver disease
Link established between western diets high in fat and sugar and the development of non-alcoholic fatty liver disease, the leading cause of chronic liver disease.
Tackling tuberculosis: Continuing problems but grounds for optimism
Paul Sommerfeld, Executive Trustee, TB Alert and Chair, TB Europe Coalition, walks us through tackling tuberculosis. We hear that while there are continuing problems, there are finally grounds for optimism.
Treatments for Alzheimer’s disease: understanding causes, diagnosis, prevention & cure
Abbas Kanani, Superintendent Pharmacist at Chemist Click Online Pharmacy, walks us through treatments for Alzheimer’s disease, researching the causes, diagnosis, prevention, and cure.
What we need to know about living with diabetes
Abbas Kanani, Superintendent Pharmacist at Chemist Click Online Pharmacy, walks us through what we need to know about living with diabetes, starting with a comment on prediabetes.
AI can predict future ulcerative colitis flare-ups
AI model could predict ulcerative colitis flare-ups and complications after reading biopsies taken during colonoscopies.
Improve patients’ lives with inflammatory bowel disease
Dr Joana Torres, Gastroenterologist, Expert in Clinical IBD and UEG* Rising Star Awardee, highlights the most challenging aspects of living with inflammatory bowel disease and the unmet medical needs in IBD management.
Understanding amyloid beta and Alzheimer’s disease: the key to helping AD patients
Efforts to prevent or treat Alzheimer’s Disease (AD) by targeting Amyloid beta (Aβ) assemblies should be continued, but the strategies should be altered dramatically.
An HPV factsheet – Everything you need to know
HPV is the most common STI in the world, affecting 80% of the population. Here Dr Deborah Lee, from Dr Fox Online Pharmacy, addresses the most common issues about HPV in an attempt to aid in the understanding of the condition
Multiple sclerosis symptoms: How to get a diagnosis
Christen Richards, Committee Member from MS Society Jersey, unpacks multiple sclerosis symptoms for us, focusing on recognising the key points to help the diagnostic process.
Molecular aspects of Global Infection Prevention and Control
Dr Zisis Kozlakidis directs our thoughts towards the molecular aspects of global Infection Prevention and Control, in this the second of a special two-part series.
Understanding Amyloidosis, a group of rare diseases
In this interview, Abbas Kanani, MRPharmS, Superintendent Pharmacist at Chemist Click, tells us about amyloidosis, a group of rare diseases in which abnormal proteins deposit as amyloid in tissues and organs.
PKG (Personal Kinetigraph): Helping my Parkinson’s Disease patients
Parkinson’s Disease affects all activities of patient daily living but PKG can help.
Incontinence treatment through bioelectrical implant therapy
In a current incontinence treatment, researchers are exploring how to physically regulate bladder function by bioelectrical implant signals.
Where are Mexico’s dengue fever hotspots?
As many as one in five dengue fever deaths in the Americas occur in Mexico, which is why identifying dengue fever hotspots is so important.
Schistosomiasis: Put parasitic infections on the map
Wendy Harrison, CEO of the SCI Foundation, outlines the importance of putting parasitic infections on the map, with a particular focus on schistosomiasis.
Early Alzheimer’s disease detection sensor in development
Researchers are developing a new Alzheimer's disease detection sensor that can be used in the early stages of Alzheimers and a number of other diseases.
Degenerative eye disease and the opportunities of ophthalmic drug development
Eric Buckland of Translational Imaging Innovations looks at ophthalmic drug development and how better clinical endpoints can improve success rates.
